Zhao Li - Net Worth and Insider Trading
Zhao Li Net Worth
The estimated net worth of Zhao Li is at least $593 Million dollars as of 2025-03-02. Zhao Li is the 2202 Interest of your spouse of Ascentage Pharma Group International and owns about 15,779,576 shares of Ascentage Pharma Group International (HKSE:06855) stock worth over $593 Million. Details can be seen in Zhao Li's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Zhao Li has not made any transactions after 2022-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Zhao Li
Zhao Li Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Zhao Li owns 1 companies in total, including Ascentage Pharma Group International (HKSE:06855) .
Click here to see the complete history of Zhao Li’s form 4 insider trades.
Insider Ownership Summary of Zhao Li
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06855 | Ascentage Pharma Group International | 2022-08-10 | 2202 Interest of your spouse |
Zhao Li Latest Holdings Summary
Zhao Li currently owns a total of 1 stock. Zhao Li owns 15,779,576 shares of Ascentage Pharma Group International (HKSE:06855) as of August 10, 2022, with a value of $593 Million.
Latest Holdings of Zhao Li
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06855 | Ascentage Pharma Group International | 2022-08-10 | 15,779,576 | 37.55 | 592,523,079 |
Holding Weightings of Zhao Li
Zhao Li Form 4 Trading Tracker
According to the SEC Form 4 filings, Zhao Li has made a total of 2 transactions in Ascentage Pharma Group International (HKSE:06855) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ascentage Pharma Group International is the sale of 65,200 shares on August 10, 2022, which brought Zhao Li around $1 Million.
Insider Trading History of Zhao Li
- 1
Zhao Li Trading Performance
Zhao Li Ownership Network
Ownership Network List of Zhao Li
Ownership Network Relation of Zhao Li
Zhao Li Owned Company Details
What does Ascentage Pharma Group International do?
Who are the key executives at Ascentage Pharma Group International?
Zhao Li is the 2202 Interest of your spouse of Ascentage Pharma Group International. Other key executives at Ascentage Pharma Group International include 2201 Interest of corporation controlled by you JPMorgan Chase & Co. , 2201 Interest of corporation controlled by you Takeda Pharmaceuticals Company Limited , and 2101 Beneficial owner Takeda Pharmaceuticals International AG .
Ascentage Pharma Group International (HKSE:06855) Insider Trades Summary
Over the past 18 months, Zhao Li made no insider transaction in Ascentage Pharma Group International (HKSE:06855). Other recent insider transactions involving Ascentage Pharma Group International (HKSE:06855) include a net sale of 0 shares made by JPMorgan Chase & Co. , a net sale of 0 shares made by Zhai Yifan , and a net sale of 0 shares made by Yang Dajun .
In summary, during the past 3 months, insiders sold 0 shares of Ascentage Pharma Group International (HKSE:06855) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ascentage Pharma Group International (HKSE:06855) were sold and 48,614,644 shares were bought by its insiders, resulting in a net purchase of 48,614,644 shares.
Ascentage Pharma Group International (HKSE:06855)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ascentage Pharma Group International Insider Transactions
Zhao Li Mailing Address
Above is the net worth, insider trading, and ownership report for Zhao Li. Currently GuruFocus does not have mailing address information for Zhao Li.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
